The position
will be based out of Copenhagen, Denmark. Qualifications Master’s degree in a relevant field. You have comprehensive market access experience ( years), both from strategic and operational market access roles. Experience within pharmaceutical industry and/or a consultancy company for a pharmaceutical client, will be a requirement. You show a high degree of business and industry insight, and you have solid experience with setting the direction and the strategy for your area. To have experience from Headquarters and/or global teams, will be a clear advantage. As a person you have excellent communication and stakeholder engagement skills, strong commercial understanding. a high degree of ambition, personal drive and ability to work independently. It comes natural for you to identify new and innovative approaches when driving projects and deliverables related to our assets. As well, you are fluent in both written and spoken English. About the department The CETA Market Access team sets the payer-facing direction for Novo Nordisk’s future drug portfolio within the Cardiovascular and Emerging Therapies (CETA) franchise: cardiovascular disease, kidney disease, Alzheimer’s disease, and MASH/liver disease. As such, the team provides strategic input to the value and launch strategy and payer requirements for our pipeline products across the franchise. Together with our good colleagues across Novo Nordisk, we are proud to be a key partner in the commercial success of the long-term future of Novo Nordisk. While sharing a pursuit of ambitious goals we’re also committed to maintaining a healthy and creative work culture and work-life balance.Husk at skrive i din ansøgning, at du så jobbet hos Ofir